Cholesterol is not the villain it has been made out to be. It is an essential molecule involved in hormone production, cell membrane integrity, vitamin D synthesis, and bile acid formation. The clinical story of cholesterol is far more nuanced than the total number that most people receive. LDL particle size and number, HDL quality, triglycerides, the triglyceride-to-HDL ratio, oxidised LDL, and inflammatory markers are all part of the cardiovascular risk picture that total cholesterol alone cannot tell.
Nutritional support for cholesterol health works best when it is targeted to the specific lipid pattern and its underlying drivers not applied as a generic cholesterol-lowering protocol. I read your full lipid picture โ particle size, the triglyceride-to-HDL ratio, and inflammatory markers โ and target your specific pattern, rather than treating your total cholesterol number alone.
Not all LDL is equal. Small, dense LDL particles are highly atherogenic they penetrate the arterial wall and oxidise readily. Large, fluffy LDL is largely benign. Standard lipid panels measure total LDL-C (cholesterol content) not particle size or number. Two people with the same LDL-C can have very different atherogenic risk depending on their particle pattern. High refined carbohydrate and sugar intake promotes the small dense pattern; the Mediterranean dietary approach promotes the large buoyant pattern.
HDL is cardioprotective through its role in reverse cholesterol transport removing cholesterol from arterial walls. Low HDL is often a metabolic signal associated with insulin resistance, inflammation, and gut dysbiosis. Raising HDL through dietary means (omega-3s, olive oil, exercise, reducing refined carbohydrates) is more impactful than the number alone suggests.
Elevated triglycerides are driven almost entirely by refined carbohydrates, sugar, and alcohol not dietary fat. A triglyceride: HDL ratio above 3.0 (mmol/L) is a reliable marker for insulin resistance and small dense LDL and is often more clinically useful than the total LDL number for cardiovascular risk assessment.
LDL becomes atherogenic when it is oxidised. The oxidation of LDL driven by poor antioxidant status, smoking, blood sugar instability, and chronic inflammation is more relevant to cardiovascular risk than LDL quantity alone. Antioxidant nutrition reduces LDL oxidation and is more clinically targeted than LDL reduction alone for many patients.
The nutritional approach differs significantly depending on the driver. Identifying which of these is most active determines what the plan needs to address.
The most common driver of unfavourable lipid patterns elevating triglycerides, lowering HDL, and promoting the small dense LDL pattern. Addressing insulin resistance through nutrition is an important part of the cardiovascular risk picture, alongside any cholesterol-lowering treatment your physician has recommended.
Fructose and refined carbohydrates are the primary dietary drivers of elevated triglycerides and unfavourable lipid patterns not dietary fat. This is now well established. Reducing refined carbohydrate intake consistently improves the lipid picture more effectively than fat reduction in patients with metabolic dyslipidaemia.
The gut microbiome produces secondary bile acids that influence cholesterol metabolism. Dysbiosis disrupts bile acid cycling, impairing cholesterol clearance and contributing to unfavourable lipid patterns. Microbiome support through dietary fibre diversity is a meaningful upstream intervention.
One of the most commonly missed causes of elevated LDL. The thyroid regulates LDL receptor activity when thyroid function is impaired, LDL clearance slows. Thyroid function should always be assessed alongside elevated LDL that does not respond as expected to dietary change.
Familial hypercholesterolaemia a genetic condition significantly elevating LDL from birth requires specific medical management. Nutritional support complements but does not replace medical treatment in FH. Genetic factors should be considered where LDL is very elevated without clear metabolic or dietary drivers.
Inflammation drives LDL oxidation and promotes the atherogenic small dense particle pattern. Addressing inflammatory load through nutrition reducing ultra-processed foods, supporting the gut microbiome, and optimising omega-3 status targets cardiovascular risk at a more upstream level than lipid-lowering alone.
Mediterranean-style eating olive oil as primary fat, fish twice weekly, abundant vegetables, legumes, and whole grains consistently shows benefit for cardiovascular risk markers including lipid profiles, inflammatory markers, and endothelial function.
Soluble fibre from oats, legumes, psyllium, and flaxseed binds bile acids in the gut, interrupting cholesterol recycling and lowering LDL. One of the most evidence-based dietary interventions for LDL reduction and a structural part of the cholesterol nutritional plan.
EPA and DHA from fatty fish and quality supplements are among the most evidence-based nutritional interventions for reducing elevated triglycerides and support HDL quality, reduce LDL oxidation, and have anti-inflammatory cardiovascular benefits beyond lipid numbers.
Reducing refined carbohydrates and stabilising blood sugar is the one of the most impactful nutritional intervention for triglycerides and the triglyceride:HDL ratio addressing the metabolic root cause of the most common unfavourable lipid pattern seen in clinical practice.
Naturally occurring in nuts, seeds, and legumes and present in higher amounts in fortified foods. Block intestinal cholesterol absorption and consistently reduce LDL by 5โ15% when consumed regularly as part of a lipid-focused plan.
Reduce LDL oxidation, support HDL function, and have anti-inflammatory effects. Found abundantly in olive oil, berries, dark chocolate, green tea, and colourful vegetables the foods that characterise the Mediterranean dietary pattern.
Ayurveda addresses unfavourable lipid patterns through the lens of Kapha accumulation and Meda Dhatu (fat tissue) imbalance when Medodhatvagni (the metabolic fire of fat tissue) is impaired, fat metabolism becomes sluggish and the body's ability to process and clear lipids efficiently declines.
When Kapha-aggravating foods and habits dominate excess sweet, sour, and oily foods; sedentary lifestyle; irregular eating Medodhatvagni becomes impaired. The Kapha-reducing dietary approach directly supports lipid metabolism: light, warm, dry foods; bitter, pungent, and astringent tastes.
The liver is the central metabolic organ in both Ayurvedic and modern medicine responsible for cholesterol synthesis, metabolism, and clearance. Supporting hepatic Agni through digestive fire-kindling dietary practices, and meal timing aligned with the body's natural digestive rhythm addresses lipid metabolism at its Ayurvedic root.
Reviewing your full lipid panel through a functional lens โ including the triglyceride:HDL ratio, not just total cholesterol. Understanding which pattern you have and identifying the most likely driver: metabolic, inflammatory, thyroid, genetic, or dietary.
A plan targeted to your specific lipid pattern and its driver โ not a generic low-fat or low-cholesterol diet. Addressing the metabolic root where relevant, the inflammatory component where indicated, and the specific dietary factors most impactful for your pattern.
Regular follow-up to track lipid panel response alongside symptom and dietary changes. Lipid profiles typically require 8โ12 weeks to reflect dietary changes meaningfully โ monitoring timelines and target markers are discussed alongside the GP's monitoring schedule.
Book a free 15-minute call a conversation about your lipid picture and what a targeted nutritional approach might involve.
The entire contents of this website are based upon the opinions of Manjiri Nadkarni (Manjiri Nadkarni Consulting) and is meant for educational purposes only and does not constitute medical/ psychological advice . Please note that Manjiri Nadkarni is not a dietitian, physician or other licensed healthcare professional in Canada. She is a Doctor of Ayurvedic Medicine - MD (Ayurveda) (licensed and regulated in India but not Canada), Registered Holistic Nutritionist as well as Oncology Nutrition Consultant.
The content on this website is not intended to diagnose or treat any diseases. The information on this website is NOT intended as medical or psychological nor is it intended to replace the care of a qualified health care professional. Always consult with your primary care physician or licensed healthcare provider for all diagnosis and treatment of any diseases or conditions, for medications or medical advice as well as before changing your health care regimen.

Manjiri Nadkarni
BAMS ยท MD Ayurveda-India ยท India Trained Ayurvedic Medicine Doctor (Not a licensed medical doctor in Canada)
Registered Holistic Nutritionist (RHN)
Natural Nutrition Clinical Practitioner (NNCP)
Certified Oncology Nutrition Consultant (ONC)
Advanced Integrative Metabolic Consultant (in progress)
Copyright 2026. Manjiri Nadkarni . All Rights Reserved.